Trial reportFrontiers in endocrinology2025
Maintained diabetes remission among normal BMI individuals achieved without ongoing intervention: a three-year follow-up study of intermittent calorie restriction.
Trial report in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinicopathological predictors of central lymph node metastasis in clinically node-negative papillary thyroid carcinoma: a retrospective cohort analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Even when diabetes remission is achieved and maintained through weight loss, relapse is likely if body weight and consequently BMI increase again. This study aims to evaluate the maintenance of remission without ongoing intervention among participants who achieved diabetes remission and normal BMI through intermittent energy restriction. Research design and methods: This study was a randomized controlled trial with parallel-design and open-label. The intervention group received a three-month Chinese Medical Nutrition Therapy (CMNT) diet intervention consisting of six 15-day cycles. Each cycle encompassed five consecutive days of energy restriction (840 kcal/day), succeeded by 10 days of ad libitum eating. During the ad libitum dietary phase and the subsequent 3-year follow-up, participants self-selected food according to the Chinese Dietary Guidelines for Diabetes (2017 edition). Eventually, their HbA1c, fasting blood glucose (FBG), antidiabetic medication use, weight, quality of life, and complications were assessed. Results: After 3 years of follow-up, 75% of participants in the CMNT group maintained diabetes remission compared to none in the control group. The maintenance of remission was found to be positively correlated with the extent of withdrawal of insulin or insulinotropic agent through the intervention. However, for people whose BMI is below 24 kg/m², regaining weight did not affect the maintenance of remission. Additionally, the CMNT group exhibited significant improvements in quality of life, along with lower rates of complications, hospitalizations, and all-cause mortality. Conclusion: For individuals with normal BMI, after following a three-month CMNT, diabetes remission is observed over three years without ongoing structured maintenance. Clinical Trial Registry: chictr.org.cn, identifier ChiCTR2000038036.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.